bpc-157 fda warning 2025 september human clinical trial evidence safety Peptides are nearly everywhere in fitness marketing fda warning letters bpc-157 sellers

Research Limitation: Neither peptide has completed Phase 3 human clinical trials for tissue healing indications

A Vitamin B12 deficiency may lead to various health problems, ranging from fatigue to permanent neurological changes

Neither BPC-157 nor TB-500 has received FDA approval for human therapeutic use

Third-Party Tested: Ensures purity, potency, and safety in every batch

A controlled study (PMID: 7777652) found that DSIP did not significantly affect CRH- or meal-induced ACTH and cortisol secretionindicating DSIP does not measurably blunt the human cortisol response, contrary to stress-protective effects suggested by some animal studies